Ravi Goyal serves as Vice Chair of Research and Tenured Professor in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Tucson. He leads the department's research portfolio across clinical and basic-science programs, mentors junior faculty and graduate trainees, and builds the infrastructure that makes translational women's-health science possible at one of the Southwest's largest academic medical centers.
His own laboratory studies how exposures during fetal and early-postnatal life — hypoxia, undernutrition, environmental stressors — reprogram the maternal and offspring cardiovascular system and predispose to disease decades later. The lab combines molecular epigenetics, vascular physiology, and computational modeling to identify mechanisms that can be modified before symptoms appear.
Dr. Goyal is a Fellow of the American Heart Association (FAHA), a NIH-funded Principal Investigator with more than $14 million in direct grant awards, and an active peer reviewer for the NIH, the American Heart Association, the Swiss National Science Foundation, and over 30 international journals. He holds the MD, PhD, and MBA degrees, an unusual combination that informs how he bridges discovery science, clinical translation, and the commercial pathways that bring innovations to patients.
Outside the university, he is founder and CEO of Epigenuity® LLC — a Tucson-based translational venture advancing devices and software for maternal-fetal medicine and women's health.